Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Charles Coombes, MD, PhD, Imperial College London, London, UK, provides an overview of the REACT study (NCT02429427), a randomized clinical trial evaluating the effect of celecoxib versus placebo as adjuvant therapy on disease-free survival among patients with breast cancer. This interview took place at the San Antonio Breast Cancer Symposium 2021 in San Antonio.